<DOC>
	<DOCNO>NCT01403389</DOCNO>
	<brief_summary>The purpose study determine Eculizumab safe effective prevention delay graft function follow decease donor kidney transplantation .</brief_summary>
	<brief_title>A Study Activity Eculizumab Prevention Delayed Graft Function In Deceased Donor Kidney Transplant</brief_title>
	<detailed_description>Based experimental data supportive observation human associate complement gene upregulation ischemic reperfusion injury , hypothesize C5 cleavage key step pathogenesis ischemic reperfusion injury follow transplantation . It hypothesize eculizumab , antibody block C5 cleavage human effective prophylactic agent prevent ischemic reperfusion injury high risk recipient . To test hypothesis , study pilot prospective , randomize study test efficacy eculizumab vs. placebo give time transplantation prevent delay graft function first adult recipient decease donor kidney .</detailed_description>
	<mesh_term>Delayed Graft Function</mesh_term>
	<criteria>Age 18 old Weight &gt; 40 kg Male Female Recipients first decease donor kidney Able provide write informed consent Transplant candidate per site specific guideline Dialysis dependent renal failure ( initiated 2 month prior transplant ) Novartis Delayed Graft Function Score 38 Extended criterion donor brain death , standard criterion donor cold ischemic time &lt; 24 hour Planned receive multiorgan transplant Kidneys donor &lt; 6 year age Dual kidney transplant ( donor , include en bloc ) Living donor kidney Highly sensitize recipient ( PRA &gt; 50 % ) Previous transplant Participation another investigational trial Recipient BMI &gt; 40 ABO incompatible DCD Donor Preemptive kidney transplant Recipients DGF score &lt; 3 &gt; 8 Women pregnant breast feed Women child bear potential unable unwilling use medically acceptable form contraception Patients infect HIV , HCV HBV Active bacterial infection clinically significant opinion investigator Patients history splenectomy Patients history meningococcal disease Patients know suspect hereditary complement deficiency Patients history cancer ( nonmelanoma skin cancer ) within last 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Kidney Transplant</keyword>
	<keyword>Delayed Graft Function</keyword>
</DOC>